Dendritic cells-based vaccine to inhibit triple-negative breast cancer cells proliferation.
/in Breast Cancer, Dendritic Cells, International Publications /von 2016-06-05 / J Clin Oncol 34, 2016 (suppl; abstr e12566)Safety and initial clinical efficacy of a dendritic cell (DC) vaccine in locally advanced, triple-negative breast cancer (TNBC) patients (pts).
/in Breast Cancer, Dendritic Cells, International Publications /von 2016-06-05 / J Clin Oncol 34, 2016 (suppl; abstr 1086)Impact of CD8 stromal lymphocytes in BC patients with the addition of autologous dendritic CELL vaccination to neoadjuvant chemotherapy.
/in Breast Cancer, Dendritic Cells, International Publications /von 2016-06-05 / J Clin Oncol 34, 2016 (suppl; abstr 1081)5-year follow up for 72 metastatic melanoma patients treated with eltrapuldencel-T (CLBS20) vaccine.
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2016-06-05 / J Clin Oncol 34, 2016 (suppl; abstr 3090)Association of increased survival in glioblastoma patients treated with dendritic cell vaccinations and temozolomide with increased activity of NK cells and ABCC3 expression.
/in Dendritic Cells, Glioblastoma, International Publications /von 2016-06-04 / J Clin Oncol 34, 2016 (suppl; abstr 2039)Immune effects by selective heating of membrane rafts of cancer-cells.
/in Hyperthermia, International Publications /von 2016-06-03 / J Clin Oncol 34, 2016 (suppl; abstr e14571)Dendritic cell vaccine transduced with ubiquitin-mesothelin fusion gene for pancreatic cancer.
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2016-06-03 / J Clin Oncol 34, 2016 (suppl; abstr e14586)A feasibility and safety study of vaccination with Poly-ICLC and peptide-pulsed dendritic cells in patients with advanced pancreatic adenocarcinoma.
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2016-06-03 / J Clin Oncol 34, 2016 (suppl; abstr e14579)Recent advances in immuno-oncology and its application to urological cancers
/in Dendritic Cells, Hypernephroma, International Publications, Newcastle Disease Virus, Prostate Cancer, Urothelial Carcinoma /von 2016-06-03 / BJU Int. 2016 10;118(4):506-14
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de